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The genomes of filamentous fungi comprise numerous putative gene clusters coding for the biosynthesis of chemically and
structurally diverse secondary metabolites (SMs), which are rarely expressed under laboratory conditions. Previous approaches
to activate these genes were based primarily on artificially targeting the cellular protein synthesis apparatus. Here, we applied an
alternative approach of genetically impairing the protein degradation apparatus of the model fungus Aspergillus nidulans by
deleting the conserved eukaryotic csnE/CSN5 deneddylase subunit of the COP9 signalosome. This defect in protein degradation
results in the activation of a previously silenced gene cluster comprising a polyketide synthase gene producing the antibiotic 2,4-
dihydroxy-3-methyl-6-(2-oxopropyl)benzaldehyde (DHMBA). The csnE/CSN5 gene is highly conserved in fungi, and therefore,
the deletion is a feasible approach for the identification of new SMs.
Since its discovery by Fleming in the 1920s, fungal penicillin hassaved the lives of millions. Currently, theWorld Health Orga-
nization forecasts that the dramatic increase in antimicrobial re-
sistance all over the worldmight lead to a disaster and proclaims a
need for novel drugs (22). Certain fungi, plants, and bacteria pro-
duce various potent secondarymetabolites (SMs) that span awide
field of structurally and chemically diverse natural products.With
almost 1.5 million species (33), the fungal kingdom is a major
reservoir for bioactive natural products as beneficial antibiotics
and antitumor drugs but also as deleterious mycotoxins and food
contaminants (28, 38). Although many fungal SMs have been de-
scribed and tested, their complete potential is by far not exploited.
In recent years, different approaches were applied to find novel
bioactive SMs either in new species or in already establishedmodel
organisms. New geographical spots exhibiting extreme conditions
were explored in order to find new species producing as-yet-un-
known natural products (37). An alternative approach is the ex-
ploration of the full genomic potential of already known species by
genomic mining (13, 14, 30, 76). Genomic sequencing revealed
that there are many more genes for the biosynthesis of SMs than
themetabolites already identified. These genes are often clustered,
butmost of themare rarely expressed under laboratory conditions
(35), making the identification of their chemical products chal-
lenging. Two major strategies were applied to activate hidden
genes: (i) changing the environment or (ii) genetic engineering
(19, 35, 56). (i) The OSMAC (one strain, many compounds) ap-
proach activates silent gene clusters by cultivating microorgan-
isms under different conditions (10, 75). Alternatively, physical
contact with an opponent results in the uncovering of hidden
clusters by activating defense mechanisms (58). (ii) Genetic engi-
neering is focused primarily on expressing complete gene clusters
in heterologous hosts (53, 77) or on altering the cellular transcrip-
tion or protein synthesis machinery. Thus, SM synthesis was en-
hanced by changing genes with regulatory (12, 59), ribosomal (36,
49), protein-modifying (57, 64), or chromatin-modifying (11, 48,
61) functions or by adding epigenetic modifiers with DNAmeth-
yltransferase or histone deacetylase inhibiting function (26, 34,
70). A more selective approach is the artificial expression of a
specific transcription factor (TF) gene embedded in a silenced
gene cluster, which is able to activate SM synthesis (8, 20), or the
direct expression of the biosynthetic genes by an inducible pro-
moter (1).
Here, we describe the proof of principle of an alternative ge-
netic approach to discover products of silent SM genes by impair-
ing the control of the protein destruction machinery. Most nu-
clear and cytoplasmic proteins, includingmany TFs, are degraded
by the proteasome pathway, which requires the ubiquitin labeling
of target proteins. The activity of the multiprotein COP9 signalo-
some complex (CSN) plays a crucial role in controlling this pro-
cess (71). In its fifth subunit, CSN5/CsnE, there resides a dened-
dylase catalytic activity, which detaches the ubiquitin-like protein
Nedd8 from cullin-based ubiquitin E3 ligases. The covalent link-
age of Nedd8 to a lysine residue of cullins activates E3 enzymes,
which control ubiquitin-mediated protein degradation in the cell
(15). The deletion of the gene for CSN5/CsnE, which is highly
conserved in eukaryotes, results in embryonic death in plants or
animals but results in viable fungal mutant strains altered in sec-
ondarymetabolism and development (69). This suggests that reg-
ulators of secondary metabolism and development cannot be de-
graded properly, resulting in the false expression of SM genes. We
used this approach in combination with a recently established
technique targeting TFs (8, 20) to identify as-yet-undescribed SM
clusters for the model ascomycete Aspergillus nidulans. Genomic
sequencing predicted 32 polyketide synthases (PKSs), 27 nonribo-
somal peptide (NRP) synthases, and 6 dimethyl-allyl-tryptophan
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synthetases inA. nidulans (12, 58, 66), but only a few of them have
been identified. The control of secondary metabolism and devel-
opment is coordinated at the molecular level (5, 6, 74) and re-
quires an intact CSN (15, 17, 18). The identification and deletion
of the conserved CSN5/csnE genes might be accomplished even if
an interesting fungal genome is not yet sequenced. Therefore, fun-
gal CSN5/csnE mutant strains are an interesting reservoir for the
discovery of novel SMs.
MATERIALS AND METHODS
Strains and growth conditions. Strains used in this study are listed in
Table S1 in the supplemental material. Aspergillus nidulans strains were
grown on minimal medium (0.52 g/liter KCl, 0.52 g/liter MgSO4, 1.52
g/liter KH2PO4, 0.1% trace element solution [pH 6.5]) (4) at 30°C or 37°C
and supplemented appropriately with 1 g/ml pyridoxine-HCl, 1 g/ml
uracil, 0.25 g/ml uridine, 1 g/ml 4-aminobenzoic acid, 1 g/ml pyri-
thiamine (TaKaRa Bio Inc.,Münsing, Germany), 120g/ml nourseothri-
cin-dihydrogen sulfate (clonNAT;Werner BioAgents, Jena, Germany), 80
g/ml phleomycin (Cayla-InvivoGen, Toulouse, France), and 5 mg/plate
DHMBA. D-Glucose (1%) served as the carbon source, and 10mMnitrate
or ammonium served as the nitrogen source. For solid medium, 2% agar
was added. For the induction of sexual development, cultures were grown
in the dark under oxygen limitation conditions, and for the induction of
asexual development, cultures were grown in light (21). Escherichia coli
strains DH5 and MACH-1 (Invitrogen GmbH, Karlsruhe, Germany)
were used for the preparation of plasmid DNA and were cultivated in LB
medium (1% tryptone, 0.5% yeast extract, 1% NaCl) supplemented with
100 g/ml ampicillin or 50 g/ml kanamycin. Bacterial strains for bioac-
tivity tests were propagated on LB medium. Sordaria macrospora cells
were grown on BMMmedium (2.5%maizemeal, 0.8% biomalt [pH 6.5])
(25). Verticillium longisporum cells were propagated on SXM medium
(0.2% sodium pectin, 0.4% casein, 0.52 g/liter KCl, 0.52 g/liter MgSO4,
1.52 g/liter KH2PO4, 0.1% trace element solution [pH 6.5]), and Neuro-
spora crassa cultures were grown on Vogel’s minimal medium with 2%
sucrose (65). For MIC tests,Micrococcus luteus cells were grown in Muel-
ler-Hinton broth (Carl Roth, Karlsruhe, Germany).
Strain and plasmid constructions. Strains and plasmids generated
and used in this study are listed in Tables S1 and S2 in the supplemental
material. For construction details, see the supplemental material.
Transformation procedures. Transformation in A. nidulanswas per-
formed by the polyethylene glycol-mediated fusion of protoplasts, as de-
scribed previously (24). Transformation in E. coli was performed with
calcium/manganese-treated cells (32).
Analysis of secondary metabolites. (i) General experimental proce-
dures. 1H nuclear magnetic resonance (NMR) spectra were recorded on
Varian Mercury-Vx 300 (300 MHz) and Varian VNMRS-300 (300 MHz)
spectrometers. 13C-NMR spectra were recorded on a Varian Inova-500
spectrometer (125.7 MHz). Electrospray ionization mass spectrometry
(ESI-MS) data were acquired by using a Finnigan LC-Qmass spectrome-
ter.High-performance liquid chromatography (HPLC)was performedby
using a system from Instrumentelle AnalytikGoebelGmbH(for analytical
HPLC, HPLC pump 420, SA 360 autosampler, Celeno UV-DAD HPLC
detector, ELSD-Sedex 85 evaporative light-scattering detector (ERC),
Nucleodur 250-mm by 3-mm 100-5 C18 end-capped (ec) column, and a
solvent system where solvent A was H2O plus 0.1% trifluoroacetic acid
[TFA] and solvent B was acetonitrile plus 0.1% TFA; for preparative
HPLC, Rainin Dynamax SD-1 HPLC pump, Rainin Dynamyx UV-1
HPLC detector, Nucleodur 250-mmby 20-mm 100-5 C18 ec column, and
a solvent systemwhere solvent AwasH2O and solvent B was acetonitrile).
(ii) Cultivation. One liter of liquid minimal medium with nitrate or
ammoniumas the nitrogen sourcewas inoculatedwith 109 spores, and the
culture was grown at 37°C for 36 h. For metabolic fingerprinting by ultra-
performance liquid chromatography coupled with a time-of-flight mass
spectrometer (UPLC–TOF-MS) (see Fig. 4D), cultures were grown for 10
days at 37°C in P flasks.
(iii) Extraction. Mycelia of cultures were removed by filtering with
Miracloth, and the pH of the culture filtrate was adjusted to 5. The culture
filtrate was extracted twice with an equivalent amount of ethyl acetate.
The combined extracts were dried to yield the crude extract.
(iv) Analysis byHPLC coupledwith aUVdiode array detector (UV-
DAD). The crude extracts were dissolved in 2 ml methanol (MeOH) and
analyzed by HPLC using an analytical column under gradient conditions
(20% solvent B to 100% solvent B in 20 min).
(v) Isolation of DHMBA. After ethyl acetate extraction, the crude
extract of 2-liter cultures of strain AGB527 (grown in inducing medium)
was extracted with CH2Cl2. The resulting extract was concentrated and
chromatographed by preparative HPLC under gradient conditions (20%
solvent B to 100% solvent B in 20 min, at a flow rate of 14 ml/min).
Detection was carried out at 230 nm. DHMBA (3.9mg) was eluted at 14.4
min. For detailed chemical data, see the supplemental material.
(vi) Isolation of DHPDI.The crude extract of 7-liter cultures of strain
TNO (grown in inducing medium) was extracted with CH2Cl2. The re-
sulting extract was concentrated and fractionated by preparative HPLC
under gradient conditions (20% solvent B to 100% solvent B in 20min, at
a flow rate of 14 ml/min). Detection was carried out at 230 nm. The
fraction which eluted at 12.0 min was further chromatographed on a
Sephadex column by usingMeOH as the solvent and yielded 1.4mg of the
compound 3,3-(2,3-dihydroxypropyl)diindole (DHPDI). For detailed
chemical data, see the supplemental material.
Bioactivity tests.The potential antibiotic or antifungal activities of the
isolated metabolites DHMBA and DHPDI were tested by agar diffusion
tests. Twenty-five microliters of a methanolic solution of the substances
(c 1mg/ml) was added onto sterile filter discs (diameter, 9mm) and put
onto agar plates inoculated with Escherichia coli, Bacillus subtilis, Micro-
coccus luteus, Staphylococcus aureus, Salmonella enterica serovar Typhimu-
rium, Agrobacterium tumefaciens, Pseudomonas fluorescens, Streptomyces
griseus, Aspergillus fumigatus, Aspergillus nidulans, Verticillium longispo-
rum, Neurospora crassa, and Sordaria macrospora. Inhibition zones were
measured after 1 to 5 days at 37°C or 25°C, respectively.
The MIC was determined by a microplate assay (44). M. luteus cells
were grown overnight in Mueller-Hinton broth, and the optical density
(OD) was adjusted to 0.1. Twofold dilutions of DHMBA (2 mg/ml) and
the reference antibiotic vancomycin (2 mg/ml) were prepared with the
microtiter plates. Finally, the wells contained 100 l of Mueller-Hinton
broth with or without an inhibitor as a control. Twenty-fivemicroliters of
the bacterial suspension was added, and the plates were cultivated for up
to 24 h at 30°C. TheODwasmeasured at 630 nmwith amicroplate reader
(InfiniTe M2000 [Monochromator]; Tecan, Crailsheim, Germany). Mu-
eller-Hinton broth was used as a blank incubated under the same condi-
tions. The MIC was calculated from the highest antibiotic dilution show-
ing complete inhibition. The tests were performed independently in
triplicate.
Metabolic fingerprinting by UPLC–TOF-MS. Two biological repli-
cates of each sample were analyzed three times by UPLC (Acquity UPLC
system; Waters Corporation) coupled with a photodiode array (PDA)
detector (UPLC eLambda, 800 nm; Waters Corporation) and with an
orthogonal time-of-flight mass spectrometer (LCT Premier; Waters Cor-
poration) (see the supplemental material for detailed information).
Identification of a putative binding site for DbaA. For motif predic-
tions, the intergenic regions of the genes dbaA, dbaB/dbaC, dbaD/dbaE,
dbaF/dbaG, and dbaH/dbaI were submitted to the MEME tool (2). Only
one motif was found for all five sequences with a P value of 106 to 107
(see Table S3 in the supplemental material). This motif was next submit-
ted to the TOMTOM tool (31) for the identification of similarities to
known TF binding sites. The motif showed significant similarities to the
yeast Zn(II)2-Cys6 TFs RGT1 (P  10
3) and ECM22 (P  102). To
check the specificity of the motif found for the cluster sequences, the
FIMO tool (29) was run on the set of 25 sequences (5 cluster promoters
plus 10 promoters up- and downstream of the cluster) (see Table S4 in the
supplemental material). With a P value of 106, all cluster-specific sites
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were recovered, whereas only one additional site (in the intergenic region
between AN7893 and AN7894) was detected in the flanking promoters.
RESULTS
The A. nidulans csnE mutant activates a silent biosynthetic
gene cluster comprising a PKS gene. The A. nidulans csnEmu-
tant is deficient in the enzyme activity of COP9, which is involved
in protein turnover control (45). The mutant is sensitive to oxi-
dative stress (45) and accumulates pigments, which are absent in
the wild type (Fig. 1A). Recently, we identified several of the pig-
ments as orcinol and related phenylethers (45). Some of them
were also found during an analysis of the recently identified orsel-
linic acid gene cluster comprising orsA to orsE (AN7909 to
AN7914, respectively) (54).
We analyzed the protein-degradation-impaired A. nidulans
csnE mutant for its secondary metabolism by a genome-wide
transcriptional profiling of csnE mutant cells during develop-
ment (45). Besides genes involved in sterigmatocystin (ST) (45)
and orsellinic acid biosynthesis (see Table S5 in the supplemental
material), the analysis revealed that an uncharacterized putative
cluster containing a nonreducing PKS genewas upregulated in the
csnE strain but silenced in the wild type (AN7893 to AN7903)
(Fig. 1B). The direct PKS product was recently identified as 2,4-
dihydroxy-3-methyl-6-(2-oxopropyl)benzaldehyde (DHMBA)
(1). The cluster genes were upregulated in comparison to the wild
type in at least one developmental stage. We designated the genes
of the putative cluster dbaA to dbaI (derivative of benzaldehyde),
referring to the identified PKS gene product. The putative cluster
spans 12 genes in total (Table 1). The cluster contains two putative
TF-encoding genes, dbaA, with a Zn(II)2-Cys6 domain, and dbaG,
encoding a protein with significant similarities to other putative
fungal TFs (Aspergillus fumigatus [NCBI accession number
XP_746385, 41% identities]). The initial microarray data were
confirmed by Northern analysis of 3 randomly selected genes
(AN7893, dbaA, and dbaI) of the new putative PKS gene cluster
(Fig. 1C), suggesting that CSN is involved in the repression of this
gene cluster in wild-type A. nidulans cells.
Northern hybridization determines the borders of the dba
gene cluster. Numerous gene clusters carry a specific transcrip-
tional activator (TF) genewhich is embeddedwithin the cluster (8,
20). To determine the boundaries of the novel gene cluster and to
discriminate the effect on secondary metabolism, we designed
strains overexpressing the putative TF-encoding gene dbaA or
dbaG, respectively, under the control of the inducible nitrate re-
ductase gene promoter (see Fig. S1 in the supplemental material).
The overexpression of dbaG led to no significant changes in phe-
notype, whereas the overexpression of dbaA caused a strong ex-
tracellular pigmentation and a reduced growth diameter of the
colony (Fig. 2A). Interestingly, the pigmentation depends on pH
and is reversible: in neutral and basic milieus, the culture filtrate
was yellow, while at a pH of3, it turned colorless (Fig. 2B).
We performed Northern hybridization experiments with the
dbaA-overexpressing (OE) and dbaG-OE strains (Fig. 2C). All
genes starting from AN7893 to AN7909 (orsA) were used as
probes, where we compared the promoter-repressing and -induc-
ing conditions for the corresponding TF. The dbaG-overexpress-
TABLE 1 Encoded proteins of the dba gene cluster and their proposed
functionsa
Protein Locus tag Proposed function
Predicted
length
(aa)
DbaA AN7896 Zn(II)2-Cys6 transcription factor 595
DbaB AN7897 FAD-binding monooxygenase 393
DbaC AN11584 Protein with YCII domain 109
DbaD AN7898 General substrate transporter (MFS) 456
DbaE AN7899 Esterase/lipase 278
DbaF AN7900 FAD-dependent oxidoreductase 476
DbaG AN7901 Putative fungal transcription factor
(no conserved domain)
421
DbaH AN7902 FAD binding monooxygenase 462
DbaI AN7903 Nonreducing polyketide synthase 2,605
a aa, amino acids; FAD, flavin adenine dinucleotide.
FIG1 Deletion of the csnE subunit activates a novel putative biosynthetic gene
cluster normally silenced in the wild type. (A) Phenotype of the wild-type (wt)
and csnE strains after 3 days of asexual growth at 37°C. Pictures were taken
from the top and the bottom of agar plates. The csnE mutant accumulates
pigments around colony margins. (B) Transcriptional expression of genes in
thecsnEmutant compared to the wild type at different developmental stages
(V, vegetative; A, asexual; S, sexual; 14, 14 h; 20, 20 h; 48, 48 h). Genes with log2
ratios of3.2 and adjusted P values of0.01 were regarded as being signifi-
cantly regulated, and genes with log2 ratios of 2 and adjusted P values of
0.01 were regarded as being moderately regulated.1, significantly upregu-
lated;m, moderately upregulated;n, moderately downregulated; 0, not reg-
ulated. (C) Northern hybridization of three genes of the putative gene cluster.
Samples were taken after 20, 24, and 48 h of asexual growth (A20, A24, and
A48, respectively) and after 24 and 48 h of sexual growth (S24 and S48, respec-
tively). Expression levels of gpdA and rRNAwere used as internal controls. The
expression levels of AN7893, dbaA, and dbaI were upregulated in the csnE
mutant compared to the wild type.
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ing strain exhibited increased expression of the putative oxi-
doreductase gene dbaF only, whereas the expression levels of the
AN7893, dbaA, dbaC, and dbaD genes even decreased.
In contrast, the overexpression of dbaA coordinately upregu-
lated all consecutive genes from the AN7897 (dbaB) gene to the
PKS-encodingAN7903 (dbaI) gene (Fig. 2C), indicating that these
genes form a cluster which is controlled by the fungal Zn(II)2-Cys6
TF DbaA, encoded by the most 5=-upstream-located gene
(AN7896) (Fig. 2D). DbaA also controls the second putative TF
gene, dbaG (AN7901), suggesting a complex transcriptional con-
trol of the entire dba gene cluster.
By comparisons of the intergenic regions of the dba cluster
(AN7896 and the intergenic regions between AN7897 and
AN11584, AN7898 and AN7899, AN7900 and AN7901, and
AN7902 and AN7903), a motif shared by all five sequences was
found which is not present in the intergenic regions of the neigh-
boring genes except for the intergenic region of AN7893/7894. A
regulation for AN7893 (encoding a putative oxygenase) and
AN7894 (encoding a putative YCII-related domain) was also de-
tected in the transcriptome data (see Table S5 in the supplemental
material) but not byNorthern hybridization (Fig. 2C). The shared
motif (CT/CCG/AGA/CG/CT/A/CA/TT/A/GC) shows signifi-
cant similarities to the binding sites of the yeast Zn(II)2-Cys6 TFs
RGT1 (Ykl038w) and ECM22 (YLR228C), corroborating our
findings.
DHMBA and DHPDI are mutually exclusive metabolites. In
order to identify the SMs produced by the dba gene cluster, wild-
type and dbaA-OE strains were compared after cultivation in pro-
moter-inducing medium. Culture filtrates were extracted with
ethyl acetate and subsequently analyzed by high-performance liq-
uid chromatography coupled with a UV diode array detector
(HPLC–UV-DAD). The analysis revealed a major peak at the
10.3-min retention time with absorption maxima at 221 and 296
nm for the dbaA-OE strain and a peak at a 10.6-min retention time
with absorption maxima at 231 and 276 nm for the wild-type
strain (Fig. 3A). Interestingly, both peaks weremutually exclusive.
FIG 2 Boundaries of the dba gene cluster. (A) Phenotypes of dbaA- and dbaG-overexpressing strains. All strains were grown in inducing nitrate (NO3
) and
repressing ammonium (NH4
) media. (B) Reversible pH dependency of yellowmetabolites produced in the dbaA-OE strain grown in inducing nitrate medium
for 24 h. (C) Northern hybridization of the genes AN7893 to orsA (AN7909) defines boundaries of the dba gene cluster. Strains were grown in inducing nitrate
() and repressing ammonium ()media. The expression level of gpdAwas used as an internal control. The genes upregulated in bothNorthern andmicroarray
analyses (Fig. 1B) were designated dbaA to dbaI. (D) Scheme of the dba gene cluster. The gene cluster contains the TF gene dbaA (AN7896); the oxygenase genes
dbaB (AN7897), dbaF (AN7900), and dbaH (AN7902); the YCII domain gene dbaC (AN11584); the transporter gene dbaD (AN7898); the esterase/lipase gene
dbaE (AN7899); the TF gene dbaG (AN7901); and the PKS gene dbaI (AN7903) (Table 1).
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We determined the structures of the two compounds by nuclear
magnetic resonance (NMR) spectroscopy and mass spectrometry
after cultivating both strains in larger amounts and applying dif-
ferent chromatographicmethods formetabolite isolation (see Fig.
S2A and S2B in the supplemental material).
The compound isolated from the dbaA-OE strain was identi-
fied as DHMBA (Fig. 3B), which was recently identified as a direct
PKS product of DbaI (1). Interestingly, the UV spectrum of
DHMBAwas pH dependent. In the acidic milieu, the UVmaxima
were 221 and 296 nm, while with increasing pHs, the UVmaxima
shifted to higher values, 225, 295, and 340 nm in the neutralmilieu
and 257 and 341 nm in the basic milieu.
The compound isolated from thewild typewas identified as the
alkaloid 3,3-(2,3-dihydroxypropyl)diindole (DHPDI), which has
not been described previously for aspergilli (Fig. 3B). Interest-
ingly, the occurrence of DHPDI was medium dependent. After
cultivation in nitrate medium, DHPDI was present, while in am-
monium medium, the culture lacked DHPDI (see Fig. S2C in the
supplemental material).
Besides themajor peak, severalminor peakswere present in the
dbaA-overexpressing strain in the HPLC–UV-DAD chromato-
gram (retention times between 5 and 9 min) (Fig. 3A). Some of
these peaks showed UV-visible (UV-Vis) maxima above 350 nm,
indicating that these yellow components might contribute to the
yellow color of the culture filtrate. Analysis by UPLC–TOF-MS
revealed the exactmasses of 21 compounds, which were produced
in larger amounts in the dbaA-OE strain than in the wild type, 7 of
which had UVmaxima above 350 nm (see Table S6 in the supple-
mental material), indicating a yellow color.
DHMBA exhibits antibiotic activity in agar diffusion tests.
We analyzed the putative antibiotic activities of DHMBA and
DHPDI. In an initial screening, antibacterial and antifungal activ-
ities were tested by agar diffusion tests with different Gram-posi-
tive andGram-negative bacteria as well as filamentous fungi (for a
complete list, see Materials and Methods). The tests revealed no
antibiotic activity for DHPDI. In contrast, DHMBA showed spe-
cific antibacterial activity against the Gram-positive bacterium
Micrococcus luteus, with an inhibition zone of 2.5 cm in diameter
after 24 h of growth (Fig. 3C). Thus, we determined the MIC of
DHMBA againstM. luteus in a microplate assay. TheMIC was 3.1
g/ml. This DHMBA-mediated antibacterial activity, which
might contribute to the survival of the fungus, supports our ap-
proach of using csnE mutant strains for exploring the secondary
metabolism potential for bioactive compounds of filamentous
fungi.
Deletion of the PKS gene dbaI in thecsnEmutant results in
the loss of numerous metabolite marker candidates, including
DHMBA.For a comprehensivemetabolite analysis of the dba gene
cluster, we deleted the PKS-encoding gene dbaI in the wild-type
and csnE backgrounds (Fig. 4A; see also Fig. S3 in the supple-
mental material). The lack of pks transcripts was verified by
Northern hybridization (Fig. 4B). As expected, due to the silenc-
ing of the cluster, the deletion of dbaI in the wild type caused no
phenotypic changes, but in the csnE mutant, the deletion re-
sulted in an alteration of thecsnE-specific pigments surrounding
the colony margin (Fig. 4A). The introduction of the csnE
genomic fragment restored the wild-type and dbaI deletion phe-
notypes (not shown), and the ectopic introduction of the dbaI
gene fused to the gpdA promoter restored the csnE deletion phe-
notype (Fig. 4A).
Themetabolite production of theA. nidulans strain deficient in
the COP9 signalosome was analyzed by a metabolite fingerprint-
ing analysis. Extracellular ethyl acetate extracts of the wild-type,
csnE, dbaI, and dbaI/csnE strains were analyzed by UPLC–
TOF-MS. The intensity profiles of 895 marker candidates (P 1
106) of the positive andnegative ionizationmodeswere clustered
by training a one-dimensional self-organizing map (1D-SOM)
model (42) and were grouped into 10 prototypes (Fig. 4C; see also
Table S7 in the supplemental material). Prototypes 6 and 7 repre-
sent 184 marker candidates that were upregulated in the csnE
mutant but only when the PKS DbaI was present. Among them,
DHMBAwas detected in prototype 6 (Fig. 4D). Its productionwas
enhanced in the csnE mutant compared to wild-type levels but
ceased when dbaI was deleted. Furthermore, the recently identified
orsellinic acid (58) was detected in prototype 8 (Fig. 4D). As our
microarray results suggested, its production was augmented in the
csnEmutant compared to the wild type. In thedbaI/csnE strain,
orsellinic acid production was diminished but not ceased, indicating
cross talk between the two PKSs DbaI and OrsA, as was suggested
previously (46, 58).
Furthermore, we analyzed the influence of the TFDbaA on dba
gene cluster expression in the csnE mutant. Therefore, a dbaA
deletion strain was constructed in the wild-type and csnE back-
grounds (see Fig. S3 in the supplemental material). Like the pks
deletion, no phenotypic changes were observed in the wild-type
FIG 3 Identification of metabolites. (A) HPLC–UV-DAD chromatogram of
the wild-type (magenta) and dbaA-OE (cyan) strains. abs., absorbance. (B)
Chemical structures of 2,4-dihydroxy-3-methyl-6-(2-oxopropyl)benzalde-
hyde (DHMBA) and 3,3-(2,3-dihydroxypropyl)diindole (DHPDI). (C) Agar
diffusion tests of DHMBA and DHPDI. Agar plates were inoculated withMi-
crococcus luteus cells and grown for 24 h at 37°C. Twenty-five microliters of
DHMBA and DHPDI (1 mg/l) was spotted onto filter discs. The inhibition
zone of DHMBA was 2.5 cm.
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background, while in the csnE background, again, a change of
pigments was observed (Fig. 4A). For the dbaA/csnE mutant,
the deletion phenotype was restored by the ectopic integration of
a dbaA genomic fragment.
We tested whether the deletion of csnE increases the amount of
the TF DbaA. Therefore, we designed a ctap (tandem affinity pu-
rification [TAP])-tagged dbaA construct and expressed it in the
wild-type andcsnE backgrounds (see Fig. S3 in the supplemental
material). A Western blot experiment with the anti-calmodulin
binding peptide antibody, recognizing the calmodulin binding
peptide (CBP) of the TAP tag, showed strong production of DbaA
in the csnE background but not in the wild-type background
(Fig. 4E). Our results suggest that protein levels of the TF DbaA
accumulate in the absence of CsnE.
The oxygenaseDbaH is required for yellowpigment produc-
tion and is involved in sexual development. We designed dele-
tion mutants of all dba genes in the dbaA-OE and wild-type
backgrounds in order to deepen our understanding of the new
gene cluster and its possible function (see Fig. S4 in the supple-
mental material). Phenotypes of all deletions are summarized
in Fig. 5A. In the wild-type background, all deletions exhibited
no obvious phenotype, presumably due to the silencing of the
gene cluster. In the dbaA-OE background, the dbaB, dbaC,
dbaE, anddbaF strains showed no phenotypic changes com-
pared to the dbaA-OE strain. However, thedbaD,dbaG, and
dbaH strains largely lost the ability to produce yellow pig-
ments. For the dbaD and dbaG strains, pigment production
was observed only weakly in liquid but not on solid medium,
and the dbaH strain completely lost the yellow color and
instead produced red pigments (see Fig. S5 in the supplemental
material). Interestingly, all yellow strains had a reduced growth
diameter, whereas the strains without yellow pigments had a
growth diameter similar to that of the wild type (Fig. 5B), sug-
gesting a toxic effect of secreted metabolites.
In addition, we analyzed the DHMBA production of the
cluster deletion strains in the dbaA-OE background by HPLC
analysis. All strains still produced DHMBA but in different
amounts. While the dbaE, dbaF, and dbaG strains pro-
FIG 4 Metabolic fingerprinting of thecsnE and cluster mutants. (A) Phenotypes of TF dbaA and PKS dbaI gene deletions in wild-type andcsnE backgrounds.
ect., ectopically integrated. (B) Northern hybridization of thedbaI/csnE deletion strain. Expression levels of gpdA and csnEwere used as internal controls. (C)
Clustering of the intensity profiles of 895 metabolite marker candidates of the ethyl acetate extraction phases of the wild-type, csnE, dbaI, and csnE/dbaI
strains by 1D-SOM. The horizontal and vertical dimensions correspond to prototypes 1 to 10 and the analyzed fungus strains, respectively. Prototypes 6 and 7
(red frame) representmetabolitemarkers, which accumulate specifically in thecsnE strain. Colors ofmatrix elements represent average intensity values. For the
complete data set, see Table S7 in the supplemental material. (D) Box-whisker plots showing the relative abundances of DHMBA, which was detected in
prototype 6, and of orsellinic acid, which was detected in prototype 8. (E) Western blot of the C-terminally TAP-tagged TF DbaA. Ponceau staining is shown as
an equal loading control.
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duced reduced DHMBA amounts, the production in the
dbaH strain was enriched (Fig. 6). As DbaD contains the ma-
jor facilitator superfamily (MFS) transporter domain, we con-
clude that it might be involved in the transport of the metabo-
lites to the environment. dbaH encodes a putative oxygenase,
and due to the loss of yellow pigments and the accumulation of
DHMBA in the deletion strain, we conclude that DbaH is re-
sponsible for the synthesis of yellow pigments derived from the
oxidation of DHMBA. The block of this reaction by the dele-
tion of dbaH led to the accumulation of the putative precursor
DHMBA. In addition to metabolic changes, the developmental
phenotype was altered in the dbaH/dbaA-OE strain. The
strain was impaired in sexual development and produced very
few colorless but fertile sexual fruit bodies (cleistothecia) after
7 days of sexual growth (Fig. 5C). At this stage, cleistothecium
formation in the wild-type strain was completed. The produc-
tion of Hülle cells, which are nursing cells to support fruit body
development (55), was not affected. The few cleistothecia
gained color after 10 days of growth. However, the exogenous
addition of purified DHMBA to the growth medium of the
dbaH strain resulted in no change in sexual development.
Our results suggest that the dba gene cluster has impacts not
only on secondarymetabolismbut also on the developmental pro-
cesses of the fungus.
DISCUSSION
The identification of silent and orphan gene clusters is of broad
interest for biotechnology, including the pharmaceutical or food
industry (9, 16, 27, 38). Only a fraction of all presumed biosyn-
thetic genes and their products are known, and it is necessary to
develop new tools for the activation of silent gene clusters. We
showed here the successful application of a new approach to
awaken silenced biosynthetic gene clusters. This approach is based
on the idea that the interruption of the protein degradation ma-
chinery can lead to the increased stabilization of regulators, in-
cluding transcriptional activators for biosynthetic gene clusters.
We chose the deletion of the csnE gene, encoding a subunit of
COP9 (CSN), where we had observed metabolic changes in pre-
vious studies (17, 45). The multiprotein complex CSN is highly
conserved in eukaryotes (68) and plays a crucial role in the control
of ubiquitin-mediated protein degradation in the cell (15). The
csnE deletion mutant of A. nidulans is impaired in sexual repro-
FIG 5 Phenotypes of dba cluster deletions in the wild-type and dbaA-OE backgrounds. (A) Growth test on inducing nitrate (NO3
) and repressing ammonium
(NH4
) media. For asexual development, strains were grown for 3 days at 37°C in light. For the vegetative stage, strains were grown 24 h in liquid medium. (B)
Growth diameters of cluster deletion colonies compared to the wild-type and dbaA-OE strains. The wild-type diameter was set to 100%. Strains were grown for
3 days in light on inducing nitrate medium. Green, no production of yellow metabolites; yellow, production of yellow metabolites. (C) Phenotypes for sexual
development of thedbaH/dbaA-OE,dbaH, and wild-type strains. Strains were grown for 7 days at 37°C in the dark under conditions of limited oxygen levels.
The dbaH/dbaA-OE strain produces only a few cleistothecia with delayed pigmentation.
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duction (15, 45) and produces the bioactive benzaldehyde
DHMBA (Fig. 3B).
Previously established strategies to activate silent gene clusters
can affect single or multiple pathways of an organism, depending
on their respective targets. As all strategies have their advantages
and disadvantages, it is necessary to select the appropriate ap-
proach for the respective issue. The environmental OSMAC ap-
proach or the “interspecies cross talk” approach can activatemany
different silenced gene clusters in an organism (10, 58, 75). How-
ever, it can be tedious and difficult to determine the specific
growth conditions from a variety of parameters and organisms.
The heterologous expression of a complete gene cluster in a dif-
ferent host organism attacks single pathways (53), but PKS- and
NRPS-encoding gene clusters are especially very large,making this
strategy challenging. The expression of TF-encoding genes located
within a cluster by inducible promoters is another successful strat-
egy (8, 20) but might require many gene clusters to be tested in a
fungus. Unfortunately, gene clusters can also contain more than
one or even lack TF-encoding genes. With our approach, we at-
tacked the protein degradation machinery. In recent studies, only
protein synthesis has been targeted by ribosome engineering (36,
49) or by targeting protein modifiers (57, 64). Our CSN5-based
approach activates multiple biosynthetic gene clusters in an or-
ganism for the rapid identification of SMs. The advantages are that
no deeper knowledge of possibly present gene clusters is necessary
and that the amount of TFs in the cluster is primarily nonrelevant,
although this method (8, 20) can be combined with our approach
at a later stage of the analysis.
Transcriptional profiling of theA. nidulans csnE deletion strain
showed previously that many designated secondary metabolism
genes were misregulated (45). Besides the newly identified dba
gene cluster controlled by the TF DbaA, the recently identified
orsellinic acid gene cluster comprised of orsA to orsE (58) was also
partially upregulated in the csnE mutant (see Table S5 in the
supplemental material), which was verified by 1D-SOM data
showing orsellinic acid assigned to prototype 8 (Fig. 4D). Interest-
ingly, the dba cluster is located directly 5= upstream of the orsel-
linic acid gene cluster, and parts of the dba cluster were also up-
regulated during an orsellinic acid study reported previously by
Nielsen et al. and Schroeckh et al. (46, 58). A cooperation of the
PKSsDbaI andOrsAwas hypothesized previously byNielsen et al.
(46). Those researchers showed that both PKS deletions led to a
loss of F9775-A and F9775-B production, although both com-
pounds could not be detected during our work.
The deduced amino acid sequences of the proteins encoded by
the dba gene cluster (plus AN7893 to AN7895) were analyzed in
silico in more detail. A BLAST (NCBI) search revealed that the
amino acid sequences showed similarities to proteins of the citrin-
in-producing cluster of the mold Monascus purpureus and the
methylorcinaldehyde-producing cluster of the mold Acremonium
strictum (protein identities are given in Table S8 in the supple-
mental material). The structures of the tetraketide methylorcinal-
dehyde and DHMBA differ only in the ligand at the 3= position of
the phenol ring.
DHMBA was first isolated as a side product from the New
Zealand fungus Sepedonium chrysospermum in 2006 (43) and was
recently discovered in Aspergillus nidulans (1). Until 2006, it was
known only as an intermediate in the chemical synthesis of
azaphilones (63). Azaphilones are pigments with pyrone-quinone
structures containing a highly oxygenated bicyclic core and qua-
ternary center, like the yellow citrinin. Some of them show biolog-
ical activities such as antimicrobial and antitumor activities (23,
50, 51, 73), and recently, the application of azaphilones as future
food colorants was proposed (41). Several azaphilones have been
identified from different fungal species, like Monascus, Penicil-
lium, Epicoccum, and also Aspergillus species (20, 40, 60, 62), and
recently, the first studies delivered insight into the biosynthetic
pathway (20, 40). During the biosynthesis of asperfuranone, the
first enzyme-free intermediate was identified as a benzaldehyde
similar to DHMBA but differently substituted at the 6= position
(20). However, a hydroxylase-encoding gene is missing in the dba
cluster to convert DHMBA to an azaphilone related to asperfura-
none.
During feeding studies, 2,4-dihydroxy-3,5-dimethyl-6-(2-
oxo-3-methylpropyl)benzaldehyde, a compound similar to
DHMBAwith two additional methyl groups, was identified as the
first enzyme-free intermediate in the biosynthesis of citrinin (3).
In accordancewith this, we suggest that the PKS productDHMBA
might also be an intermediate in the synthesis of an azaphilone
related to citrinin. Osmanova et al. and Yang et al. even isolated
metabolites fromAspergillus sp. synthesized from azaphilones and
orsellinic acid (50, 72). Perhaps, the neighboring dba and ors clus-
ters work together to synthesize metabolites related to those iden-
tified previously by Yang et al. (72), as both gene clusters are acti-
vated in the csnEmutant.
The conversion of DHMBA to the yellow pigments found in
thecsnEmutant orwhen dbaA is overexpressedmight happen by
the oxidation of DHMBA by the oxygenase DbaH, whose deletion
results in the accumulation of DHMBA and a loss of yellow pig-
FIG 6 HPLC–UV-DAD chromatograms of cluster deletion strains in the
dbaA-OE background. DHMBA is produced by all strains. In the dbaD,
dbaE, anddbaF strains, the level ofDHMBAproductionwas reduced, while
in the dbaH strain, production was enriched.
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ments. Interestingly, the deletion of the oxygenase-encoding gene
dbaH in the dbaA-OE background also led to impaired sexual
development. The very few cleistothecia that were found were
delayed in pigmentation. However, the exogenous addition of
DHMBA to the growth medium of the dbaH mutant had no
influence on sexual behavior, showing that not the accumulated
DHMBA but other pleiotropic effects might trigger the defects in
sexual development. Nevertheless, we cannot exclude problems in
the uptake of exogenous DHMBA of the cells. A correlation be-
tween PKS gene cluster expression and sexual development was
recognized previously for Neurospora crassa and Sordaria mac-
rospora (47). The deletionmutant of the oxygenase-encoding gene
fbm1, which is member of a PKS gene cluster in both organisms,
also showed the formation of fewer and delayed fruit bodies. Al-
though the dbaH and fbm1 sequences show no similarities, they
might play a similar role in their organisms.
The follow-up experiments of our comparison of the dbaA-OE
mutant and the wild type resulted in a second compound isolated
fromwild-typeA. nidulans, which was 3,3-(2,3-dihydroxypropyl)
diindole (DHPDI). This indole alkaloidwas first found inmutants
of Saccharomyces cerevisiae, which were blocked in tryptophan
biosynthesis and accumulated different indole derivatives (39).
Additionally, the toxic compound was isolated from the ergot-
type symptom-causing fungusBalansia epichloë (52) and from the
North Sea alphaproteobacteriumOceanibulbus indolifex (67), but
to our knowledge, this is the first report of its isolation from asper-
gilli. Interestingly, the stability of DHPDI was pH dependent.
While the diindole was stable in a basicmilieu, at a pHof3 it was
converted into 2-oxo-3-indolyl-(3)-propan-1-ol, indole, and un-
known indole polymers (39), which presumably explains the lack
of DHPDI in ammonium-containingmedium (see Fig. S2C in the
supplementalmaterial). After cultivation in ammoniummedium,
the pH of the cultures was around 2.4, while cultivation in nitrate
medium resulted in a pH of 6.3.
Interestingly, the nitrogen-containing DHPDI, probably built
up from tryptophan by a cryptic NRPS, is not produced anymore
when dbaA is overexpressed. This might be due to pleiotropic
effects but could alsomean that there is an additional role ofDbaA
as a regulator for more than only one gene cluster. A recently
reported study showed that TFs do not exclusively regulate the
gene cluster inwhich they are embedded but that they are also able
to navigate the cross talk between gene clusters located even on
different chromosomes (7). Here, DbaA might additionally regu-
late the expression of the DHPDI-producing gene cluster. This
could be a natural cross talk but also due to the misexpression
of biosynthetic genes. Additionally, we identified the masses of
21 metabolites in the dbaA-OE strain, among them 3 nitrogen-
containing compounds, which emphasizes our hypothesis of
intercluster cross talk (see Table S6 in the supplemental mate-
rial). In the csnE strain, we observed a reduced level of pro-
duction of the aflatoxin precursor sterigmatocystin (ST) (45),
whereas the overexpression of dbaA did not affect ST produc-
tion (Fig. S6), implying an independence of dbaA from the
well-studied ST gene cluster.
Despite recent progress in the development of different strate-
gies, the identification of silent SM-producing gene clusters still
remains challenging.Our new approach based on interrupting the
protein degradation system gives a new possibility to uncover hid-
den SMs in a broader manner. We showed for the model A. nidu-
lans, as a paradigm of an SM-producing filamentous fungus, that
the deletion of CSN5/csnE results in the activation of several clus-
ters.We detected the PKS products DHMBA and orsellinic acid in
the mutant, and additionally, we identified the new metabolite
DHPDI from the wild type, which was so far not known to be
produced by aspergilli. It will be interesting in the future to see
what other SMs can be identified by further csn mutants from
other fungi or even lower plants like algae, which also promise to
have a high potential for bioactive molecules, which are urgently
required to combat multidrug-resistant microbes.
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